z-logo
open-access-imgOpen Access
The role of [18F]FDG PET/CT for gastric cancer management
Author(s) -
Ebru Salmanoğlu
Publication year - 2021
Publication title -
nuclear medicine review
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.216
H-Index - 21
eISSN - 1644-4345
pISSN - 1506-9680
DOI - 10.5603/nmr.2021.0021
Subject(s) - medicine , cancer , pet ct , positron emission tomography , nuclear medicine , radiology
Gastric cancer (GC) is a common cause of cancer-related deaths in the world. In addition to the patient's clinical history and clinical examination, nuclear medicine tools are required for diagnosis. [¹⁸F]FDG PET/CT has been commonly used for cancer patients for staging, restaging, evaluation of treatment response. This study aimed to review the current literature on the role of [¹⁸F]FDG PET/CT for GC management.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom